• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者的肌肉蛋白质周转率和低蛋白饮食。

Muscle protein turnover and low-protein diets in patients with chronic kidney disease.

机构信息

Division of Nephrology, Dialysis and Transplantation, Department of Internal Medicine and IRCCS Ospedale Policlinico San Martino, University of Genova, Genova, Italy.

出版信息

Nephrol Dial Transplant. 2020 May 1;35(5):741-751. doi: 10.1093/ndt/gfaa072.

DOI:10.1093/ndt/gfaa072
PMID:32378720
Abstract

Adaptation to a low-protein diet (LPD) involves a reduction in the rate of amino acid (AA) flux and oxidation, leading to more efficient use of dietary AA and reduced ureagenesis. Of note, the concept of 'adaptation' to low-protein intakes has been separated from the concept of 'accommodation', the latter term implying a decrease in protein synthesis, with development of wasting, when dietary protein intake becomes inadequate, i.e. beyond the limits of the adaptive mechanisms. Acidosis, insulin resistance and inflammation are recognized mechanisms that can increase protein degradation and can impair the ability to activate an adaptive response when an LPD is prescribed in a chronic kidney disease (CKD) patient. Current evidence shows that, in the short term, clinically stable patients with CKD Stages 3-5 can efficiently adapt their muscle protein turnover to an LPD containing 0.55-0.6 g protein/kg or a supplemented very-low-protein diet (VLPD) by decreasing muscle protein degradation and increasing the efficiency of muscle protein turnover. Recent long-term randomized clinical trials on supplemented VLPDs in patients with CKD have shown a very good safety profile, suggesting that observations shown by short-term studies on muscle protein turnover can be extrapolated to the long-term period.

摘要

适应低蛋白饮食(LPD)涉及氨基酸(AA)流量和氧化率的降低,从而更有效地利用膳食 AA 和减少尿素生成。值得注意的是,“适应”低蛋白摄入的概念已经与“适应”的概念分开,后者意味着当饮食中的蛋白质摄入不足时,即超出适应机制的限制时,蛋白质合成减少,会导致消耗。酸中毒、胰岛素抵抗和炎症是公认的机制,这些机制可以增加蛋白质降解,并在慢性肾脏病(CKD)患者中规定低蛋白饮食时损害激活适应性反应的能力。目前的证据表明,在短期内,临床稳定的 CKD 3-5 期患者可以通过降低肌肉蛋白质降解和增加肌肉蛋白质周转率的效率,有效地将其肌肉蛋白质周转率适应含有 0.55-0.6 g/kg 蛋白质的 LPD 或补充极低蛋白饮食(VLPD)。最近在 CKD 患者中进行的补充 VLPD 的长期随机临床试验显示出很好的安全性,这表明短期研究中关于肌肉蛋白质周转率的观察结果可以推断到长期。

相似文献

1
Muscle protein turnover and low-protein diets in patients with chronic kidney disease.慢性肾脏病患者的肌肉蛋白质周转率和低蛋白饮食。
Nephrol Dial Transplant. 2020 May 1;35(5):741-751. doi: 10.1093/ndt/gfaa072.
2
Is there a role for ketoacid supplements in the management of CKD?在慢性肾脏病的治疗中,酮酸补充剂是否有作用?
Am J Kidney Dis. 2015 May;65(5):659-73. doi: 10.1053/j.ajkd.2014.09.029. Epub 2015 Feb 12.
3
A practical approach to low protein diets for patients with chronic kidney disease in Cameroon.喀麦隆慢性肾病患者低蛋白饮食的实用方法
BMC Nephrol. 2016 Sep 7;17(1):126. doi: 10.1186/s12882-016-0340-5.
4
Effect of endurance training and branched-chain amino acids on the signaling for muscle protein synthesis in CKD model rats fed a low-protein diet.耐力训练和支链氨基酸对低蛋白饮食喂养的慢性肾脏病模型大鼠肌肉蛋白质合成信号传导的影响。
Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F805-F814. doi: 10.1152/ajprenal.00592.2015. Epub 2017 Jul 12.
5
Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease.低蛋白饮食联合酮酸补充治疗对慢性肾脏病糖尿病患者的安全性及有效性。
BMC Nephrol. 2018 May 9;19(1):110. doi: 10.1186/s12882-018-0914-5.
6
Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives.酮酸类似物补充在慢性肾脏病中的应用及未来展望。
Nutrients. 2019 Sep 3;11(9):2071. doi: 10.3390/nu11092071.
7
Dietary protein intake and chronic kidney disease.膳食蛋白质摄入量与慢性肾脏病
Curr Opin Clin Nutr Metab Care. 2017 Jan;20(1):77-85. doi: 10.1097/MCO.0000000000000342.
8
Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients.极低蛋白饮食补充酮酸对未透析慢性肾病患者的短期影响。
Eur J Clin Nutr. 2005 Jan;59(1):129-36. doi: 10.1038/sj.ejcn.1602050.
9
Diet as a system: an observational study investigating a multi-choice system of moderately restricted low-protein diets.饮食作为一个系统:一项调查中度限制低蛋白饮食多种选择系统的观察性研究。
BMC Nephrol. 2016 Dec 7;17(1):197. doi: 10.1186/s12882-016-0413-5.
10
Supplementation of ketoacids contributes to the up-regulation of the Wnt7a/Akt/p70S6K pathway and the down-regulation of apoptotic and ubiquitin-proteasome systems in the muscle of 5/6 nephrectomised rats.酮酸补充可促进 5/6 肾切除大鼠肌肉中 Wnt7a/Akt/p70S6K 通路的上调和凋亡及泛素-蛋白酶体系统的下调。
Br J Nutr. 2014 May;111(9):1536-48. doi: 10.1017/S0007114513004091. Epub 2014 Feb 6.

引用本文的文献

1
Type 2 diabetes mellitus with chronic kidney disease benefits from long-term restriction of dietary protein intake: a 10-year retrospective cohort study.2型糖尿病合并慢性肾脏病患者可从长期限制饮食蛋白质摄入中获益:一项10年回顾性队列研究
BMC Nutr. 2025 Jul 5;11(1):131. doi: 10.1186/s40795-025-01119-w.
2
Kidney-Gut Axis in Chronic Kidney Disease: Therapeutic Perspectives from Microbiota Modulation and Nutrition.慢性肾脏病中的肾-肠轴:微生物群调节与营养的治疗前景
Nutrients. 2025 Jun 9;17(12):1961. doi: 10.3390/nu17121961.
3
Personalized Nutrition in Chronic Kidney Disease.
慢性肾脏病的个性化营养
Biomedicines. 2025 Mar 6;13(3):647. doi: 10.3390/biomedicines13030647.
4
Should a low-protein diet and ketoanalogue supplementation be part of the management of advanced chronic kidney disease?低蛋白饮食和酮类似物补充剂是否应纳入晚期慢性肾脏病的治疗方案?
J Bras Nefrol. 2025 Jan-Mar;47(1):e20240237. doi: 10.1590/2175-8239-JBN-2024-0237en.
5
Physical activity and exercise in chronic kidney disease: consensus statements from the Physical Exercise Working Group of the Italian Society of Nephrology.慢性肾脏病患者的体力活动和锻炼:意大利肾脏病学会体力活动工作组的共识声明。
J Nephrol. 2024 Sep;37(7):1735-1765. doi: 10.1007/s40620-024-02049-9. Epub 2024 Sep 13.
6
The Role of Plant-Based Diets in Preventing and Mitigating Chronic Kidney Disease: More Light than Shadows.植物性饮食在预防和缓解慢性肾脏病中的作用:利大于弊。
J Clin Med. 2023 Sep 22;12(19):6137. doi: 10.3390/jcm12196137.
7
Association between sarcopenia and frailty in elderly patients with chronic kidney disease.老年慢性肾脏病患者肌少症与衰弱的关系。
J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1855-1864. doi: 10.1002/jcsm.13275. Epub 2023 Jun 9.
8
Diagnosis, Prevalence and Significance of Obesity in a Cohort of CKD Patients.一组慢性肾脏病患者中肥胖的诊断、患病率及意义
Metabolites. 2023 Jan 28;13(2):196. doi: 10.3390/metabo13020196.
9
TLR13 contributes to skeletal muscle atrophy by increasing insulin resistance in chronic kidney disease.TLR13 通过增加慢性肾脏病中的胰岛素抵抗导致骨骼肌萎缩。
Cell Prolif. 2022 Mar;55(3):e13181. doi: 10.1111/cpr.13181. Epub 2022 Jan 28.
10
Sarcopenia and Frailty: Challenges in Mainstream Nephrology Practice.肌肉减少症与衰弱:主流肾脏病学实践中的挑战
Kidney Int Rep. 2021 Jun 12;6(10):2554-2564. doi: 10.1016/j.ekir.2021.05.039. eCollection 2021 Oct.